STEVEN BOYD: Open Payments
NPI 1437620564 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $71 · 2025 $284
Food & beverage: $185Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $144 |
| TerSera Therapeutics LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Incyte Corporation | 1 | $14 |
Products named: Xospata, Zoladex, ENTYVIO, OJJAARA, KISQALI, VENCLEXTA, JAKAFI.
Industry payments across CO — which companies pay providers there.
